Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2026-03-17 @ 11:25 PM
Study NCT ID:
NCT03443869
Status:
COMPLETED
Last Update Posted:
2023-07-28
First Post:
2018-02-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Letermovir Versus Valganciclovir to Prevent Human Cytomegalovirus Disease in Kidney Transplant Recipients (MK-8228-002)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | CMV Disease | View |
Keywords: